These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1651994)

  • 1. Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.
    Bork E; Ersbøll J; Dombernowsky P; Bergman B; Hansen M; Hansen HH
    J Clin Oncol; 1991 Sep; 9(9):1627-31. PubMed ID: 1651994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
    Fan Y; Huang ZY; Zhang YP; Sun L
    Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teniposide in the treatment of small cell lung cancer: a review.
    Hansen HH; Dombernowsky P; Hansen M; Bork E
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):65-8. PubMed ID: 1329227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Radice PA; Bunn PA; Ihde DC
    Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
    [No Abstract]   [Full Text] [Related]  

  • 6. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
    Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB
    Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
    Goss GD; Vincent M; Corringham R; Germond C; Sinoff C; Kane G; Rowen J; Corringham S; Dhaliwal H
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):69-74. PubMed ID: 1329228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podophyllotoxins for brain metastases of small cell lung cancer.
    Haaxma-Reiche H; Berendsen HH; Postmus PE
    J Neurooncol; 1988 Nov; 6(3):231-2. PubMed ID: 2852221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.
    Montaldo PG; Figoli F; Zanette ML; Sorio R; Zucchetti M; Tirelli U; D'Incalci M
    Oncology; 1990; 47(1):55-61. PubMed ID: 2300386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
    Loehrer PJ; Ansari R; Gonin R; Monaco F; Fisher W; Sandler A; Einhorn LH
    J Clin Oncol; 1995 Oct; 13(10):2594-9. PubMed ID: 7595712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VP-16 and VM-26 plus platinum drugs combined with radiotherapy in the treatment of small cell lung cancer].
    Zeng P; Yin L; Luo B; Liu Z; Jin X
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):587-9. PubMed ID: 10806778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.
    Ettinger DS; Finkelstein DM; Sarma RP; Johnson DH
    J Clin Oncol; 1995 Jun; 13(6):1430-5. PubMed ID: 7751889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan.
    Katakami N; Takada M; Negoro S; Ota K; Fujita J; Furuse K; Ariyoshi Y; Ikegami H; Fukuoka M
    Cancer; 1996 Jan; 77(1):63-70. PubMed ID: 8630941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
    J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VM-26 and VP-16 salvage therapy for refractory germinal testicular cancers].
    Miki T; Tomooka Y; Yoshimura K; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1609-16. PubMed ID: 2593435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teniposide as single drug therapy for elderly patients affected by small cell lung cancer.
    Tummarello D; Isidori P; Pasini F; Cetto G; Cellerino R
    Eur J Cancer; 1992; 28A(6-7):1081-4. PubMed ID: 1378289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
    Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
    J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.